MedPath

TEVA-LOVASTATIN

TEVA-LOVASTATIN

Discontinued
DIN Number

02246543

Drug Class

Human

Market Date

Jan 20, 2003

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02246543
AIG Number0120669001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AA02 LOVASTATIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:06.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

LOVASTATINActive
Strength: 40 MG
Monograph: LOVASTATIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.